CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Thermogenesis Holdings Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Thermogenesis Holdings Inc
2711 Citrus Rd
Phone: (916) 858-5100p:916 858-5100 RANCHO CORDOVA, CA  95742-6228  United States Ticker: THMOTHMO

Business Summary
ThermoGenesis Holdings, Inc. develops and commercializes a range of automated technologies for cell-banking, cell-processing, and cell-based therapeutics. It provides the AutoXpress and BioArchive platforms for automated clinical bio-banking, PXP platform for point-of-care cell-based therapies and the CAR-TXpress platform for large scale cell manufacturing services. Its products include Clinical Bio-Banking Applications, Point-of-Care Applications and Large-Scale Cell Processing and Biomanufacturing. Its Clinical Bio-Banking Applications include AXP Automated Cell Separation System and BioArchive Automated Cryopreservation System. Its Point-of-Care Applications include PXP Point-of-Care System, PXP-LAVARE System and PXP-1000 System. Its Large-Scale Cell Processing and Biomanufacturing includes X-Series Products for general laboratory use and CAR-TXpress Platform for Clinical Manufacturing. AXP Automated Cell Separation System is an automated, fully closed cell separation system.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/202312/31/2022YesYes--Yes

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board, President, Chief Executive Officer XiaochunXu 52 11/13/2017 3/10/2016
Chief Financial Officer JefferyCauble 50 12/23/2019 5/10/2017
Chief Operating Officer HaihongZhu 58 3/8/2024 1/1/2022
4 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
SynGen Inc. 2711 Citrus Road Rancho Cordova CA United States

Business Names
Business Name
CARTXpress Bio Inc
Cesca Therapeutics Inc.
KOOL
4 additional Business Names available in full report.

General Information
Number of Employees: 40 (As of 12/31/2022)
Outstanding Shares: 7,952,780 (As of 3/15/2024)
Shareholders: 140
Stock Exchange: NASD
Federal Tax Id: 943018487
Fax Number: (916) 858-5199
Email Address: rruecker@thermogenesis.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, April 18, 2024